Pomerantz Law Firm Files Class Action Against Atara Biotherapeutics and Officers
Pomerantz LLP has filed a class action lawsuit against Atara Biotherapeutics, Inc. (NASDAQ: ATRA) and certain officers, alleging violations of federal securities laws. The lawsuit seeks damages for investors who purchased Atara securities between May 20, 2024, and January 9, 2026. The case is filed in the United States District Court for the Central District of California.
Tickers: $ATRA
Topics: Atara Biotherapeutics class action lawsuit Pomerantz LLP securities fraud